SPRO NASDAQ
Spero Therapeutics, Inc.
1W: -3.2%
1M: -2.5%
3M: -45.7%
YTD: -49.4%
1Y: -39.3%
3Y: -0.8%
5Y: -93.7%
$1.19
-0.07 (-5.56%)
Weekly Expected Move ±11.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$43M
Revenue
-7.0% YoY
$7M
Net Income
+113.8% YoY
$20M
Free Cash Flow
+160.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE19.2%
ROA12.9%
ROIC-128.5%
Valuation
P/E8.5
P/B1.6
EV/EBITDA10.4
Leverage
Debt/Equity0.05
Current Ratio6.12
Interest Cov.0.0x
Quality Scores
Piotroski F7/9
Altman Z-1.16
Beneish M0.00